Should You Buy CareCloud, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, CareCloud, Inc. (CCLD) scores a robust 8.4/10 on our 32-signal Quality of Company framework. At the current market price of $2.05 and a $87M market cap, our analysis maps this fundamental strength against 13 institutional-grade models to determine if a sufficient margin of safety exists.
The short answer: 5 of 7 CirclFi valuation models project upside for CareCloud, Inc. (CCLD) at $2.05 — the model consensus leans bullish, with a Quality Score of 8.4/10 and Value-Trap risk of 30/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for CareCloud, Inc. (CCLD) in 2026?
What Is the Bull Case vs the Bear Case for CareCloud, Inc. (CCLD)?
| Bull case — $8.93 target (+335.5%) | Bear case — $0.26 target (-87.5%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, CareCloud, Inc.'s quality score of 8.4/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. | According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model sees the stock as overvalued with a fair value of $0.26 (-87.5%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $2.05 and the median fair value of $6.98 implies +240.6% upside potential. | According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +423.0% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. |
| According to the CirclFi Deep Alpha Valuation Engine, the Sentiment SOTP model targets a fair value of $8.93 (+335.5%), anchoring the bull case with a methodology that provides a differentiated analytical lens. |
How Does CCLD Compare to Its Health Information Services Peers?
Valuation data pages: PHR · OPRX · VASO · GDRX · SPOK · PRVA · DH · EVH · RVRC · DOCS · HQY
Which Other Stocks Score Like CCLD on Quality?
Closest companies to CCLD’s Quality of Company score of 8.4/10, across all industries.
- HNRG — Hallador Energy Company (QOC 8.4) · analysis
- PBFS — Pioneer Bancorp, Inc. (QOC 8.4) · analysis
- AKAM — Akamai Technologies, Inc. (QOC 8.4) · analysis
- MAS — Masco Corporation (QOC 8.4) · analysis
- CHD — Church & Dwight Co., Inc. (QOC 8.4) · analysis
- RIGL — Rigel Pharmaceuticals, Inc. (QOC 8.4) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Health Information Services Screens Does CCLD Appear In?
So Is CareCloud, Inc. (CCLD) Worth Buying in 2026?
CareCloud, Inc. leans positive in our analysis — 5/7 models bullish, median fair value of $6.98 vs. $2.05, QOC 8.4/10. The case is constructive but not overwhelming, and the 2 dissenting models shouldn't be dismissed. Position sizing should reflect this moderate conviction level.
These are quantitative model outputs, not investment recommendations. CareCloud, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About CCLD Stock?
Should I buy CCLD stock right now?
Based on CirclFi's multi-model analysis, 5 of 7 models see upside for CCLD at $2.05. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 8.4/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in CareCloud, Inc.?
Key risks include: limited model coverage (7/13 active), reducing analytical confidence; wide model disagreement (3378% spread), signaling high uncertainty; general market and sector-specific risks affecting Health Information Services companies. Always diversify and consult a financial advisor.
How does CCLD compare to its competitors?
Among Health Information Services peers, CCLD holds a Quality Score of 8.4/10. Comparable companies include PHR (QOC 8.4), OPRX (QOC 8.3), VASO (QOC 8.5). The relative ranking helps investors identify whether CCLD offers better fundamental quality than alternatives in the same sector.
Is CCLD a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CCLD's Quality Score of 8.4/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy CCLD at?
CirclFi does not provide target buy prices or price alerts. However, our 7 active models produce fair value estimates ranging from $0.26 to $8.93. At $2.05, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for CCLD.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad